Compass Therapeutics, Inc. (CMPX) › Operating IncomeCompass Therapeutics, Inc. (CMPX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$34.05M2020: -$27.81M2021: -$81.88M2022: -$41.66M2023: -$50.36M2024: -$56.62M2025: -$72.84M-$72.84M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$72.84M-28.6%2024-$56.62M-12.4%2023-$50.36M-20.9%2022-$41.66M+49.1%2021-$81.88M-194.4%2020-$27.81M+18.3%2019-$34.05M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share